0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global IVF and ICSI Pipettes Market Research Report 2026
Published Date: 2026-03-30
|
Report Code: QYRE-Auto-21W17308
Home | Market Reports | Health| Reproductive Health
Global IVF and ICSI Pipettes Market Research Report 2024
BUY CHAPTERS

Global IVF and ICSI Pipettes Market Research Report 2026

Code: QYRE-Auto-21W17308
Report
2026-03-30
Pages:127
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

IVF and ICSI Pipettes Market Size

The global IVF and ICSI Pipettes market was valued at US$ 100 million in 2025 and is anticipated to reach US$ 142 million by 2032, at a CAGR of 5.2% from 2026 to 2032.

IVF and ICSI Pipettes Market

IVF and ICSI Pipettes Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on IVF and ICSI Pipettes competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
IVF (In Vitro Fertilization) and ICSI (Intracytoplasmic Sperm Injection) pipettes are specialized micro-tools used in assisted reproductive technologies to handle and manipulate gametes (eggs and sperm) and embryos with high precision. IVF pipettes are primarily used for tasks such as oocyte retrieval, embryo transfer, and other delicate procedures required during the fertilization process in vitro. ICSI pipettes, on the other hand, are specifically designed for injecting a single sperm directly into an oocyte to facilitate fertilization, particularly in cases of male infertility. These pipettes are crafted with microscopic precision to ensure minimal disruption to the cells, thereby increasing the success rates of fertilization and subsequent embryo development. Their use is critical in achieving successful outcomes in IVF treatments by allowing embryologists to perform intricate manipulations under a microscope with high accuracy.
The market for IVF (in vitro fertilization) and ICSI (intracytoplasmic sperm injection) pipettes is experiencing steady growth, driven by rising global infertility rates, increased adoption of assisted reproductive technologies (ART), and expanding fertility clinic networks, particularly in Asia-Pacific and Europe. These precision-engineered micropipettes—used for handling oocytes, sperm, and embryos—are critical consumables in ART procedures, and their demand is directly linked to the procedural volume of IVF and ICSI cycles. While the market remains niche and volume-sensitive, it benefits from high margins and recurring usage patterns, as pipettes are often single-use for sterility and quality control. Technological advances in pipette design, such as reduced tip diameter and anti-adhesion coatings, are further enhancing procedural success rates, reinforcing their value in clinical and research applications. Competitive differentiation lies primarily in manufacturing precision, material purity, and regulatory compliance (e.g., ISO 13485), with leading suppliers targeting partnerships with fertility centers and OEM microscope systems to strengthen market position.
This report delivers a comprehensive overview of the global IVF and ICSI Pipettes market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding IVF and ICSI Pipettes. The IVF and ICSI Pipettes market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global IVF and ICSI Pipettes market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist IVF and ICSI Pipettes manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of IVF and ICSI Pipettes Market Report

Report Metric Details
Report Name IVF and ICSI Pipettes Market
Accounted market size in 2025 US$ 100 million
Forecasted market size in 2032 US$ 142 million
CAGR 5.2%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Sharp Pipettes
  • Blunt Pipettes
by Application
  • Fertility Clinics
  • Hospitals
  • Research Institutes
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Cook Medical, CooperSurgical, Sunlight Medical, Vitrolife, Kitazato, Synga, Microtech, Hamilton Thorne, ASTEC Pipette, Cryo Bio System, WEIGAO, Lingen Precision Medical, FUJIFILM Irvine Scientific, Diagens Biotechnology, Optimas
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for IVF and ICSI Pipettes manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines IVF and ICSI Pipettes sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is IVF and ICSI Pipettes Market growing?

Ans: The IVF and ICSI Pipettes Market witnessing a CAGR of 5.2% during the forecast period 2026-2032.

What is the IVF and ICSI Pipettes Market size in 2032?

Ans: The IVF and ICSI Pipettes Market size in 2032 will be US$ 142 million.

Who are the main players in the IVF and ICSI Pipettes Market report?

Ans: The main players in the IVF and ICSI Pipettes Market are Cook Medical, CooperSurgical, Sunlight Medical, Vitrolife, Kitazato, Synga, Microtech, Hamilton Thorne, ASTEC Pipette, Cryo Bio System, WEIGAO, Lingen Precision Medical, FUJIFILM Irvine Scientific, Diagens Biotechnology, Optimas

What are the Application segmentation covered in the IVF and ICSI Pipettes Market report?

Ans: The Applications covered in the IVF and ICSI Pipettes Market report are Fertility Clinics, Hospitals, Research Institutes

What are the Type segmentation covered in the IVF and ICSI Pipettes Market report?

Ans: The Types covered in the IVF and ICSI Pipettes Market report are Sharp Pipettes, Blunt Pipettes

1 IVF and ICSI Pipettes Market Overview
1.1 Product Definition
1.2 IVF and ICSI Pipettes by Type
1.2.1 Global IVF and ICSI Pipettes Market Value by Type: 2025 vs 2032
1.2.2 Sharp Pipettes
1.2.3 Blunt Pipettes
1.3 IVF and ICSI Pipettes by Application
1.3.1 Global IVF and ICSI Pipettes Market Value by Application: 2025 vs 2032
1.3.2 Fertility Clinics
1.3.3 Hospitals
1.3.4 Research Institutes
1.4 Global IVF and ICSI Pipettes Market Size Estimates and Forecasts
1.4.1 Global IVF and ICSI Pipettes Revenue 2021–2032
1.4.2 Global IVF and ICSI Pipettes Sales 2021–2032
1.4.3 Global IVF and ICSI Pipettes Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 IVF and ICSI Pipettes Market Competition by Manufacturers
2.1 Global IVF and ICSI Pipettes Sales Market Share by Manufacturers (2021–2026)
2.2 Global IVF and ICSI Pipettes Revenue Market Share by Manufacturers (2021–2026)
2.3 Global IVF and ICSI Pipettes Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of IVF and ICSI Pipettes, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of IVF and ICSI Pipettes, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of IVF and ICSI Pipettes, Product Types and Applications
2.7 Global Key Manufacturers of IVF and ICSI Pipettes, Date of Entry into the Industry
2.8 Global IVF and ICSI Pipettes Market Competitive Situation and Trends
2.8.1 Global IVF and ICSI Pipettes Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global IVF and ICSI Pipettes Players Market Share by Revenue
2.8.3 Global IVF and ICSI Pipettes Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global IVF and ICSI Pipettes Market Scenario by Region
3.1 Global IVF and ICSI Pipettes Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global IVF and ICSI Pipettes Sales by Region: 2021–2032
3.2.1 Global IVF and ICSI Pipettes Sales by Region: 2021–2026
3.2.2 Global IVF and ICSI Pipettes Sales by Region: 2027–2032
3.3 Global IVF and ICSI Pipettes Revenue by Region: 2021–2032
3.3.1 Global IVF and ICSI Pipettes Revenue by Region: 2021–2026
3.3.2 Global IVF and ICSI Pipettes Revenue by Region: 2027–2032
3.4 North America IVF and ICSI Pipettes Market Facts & Figures by Country
3.4.1 North America IVF and ICSI Pipettes Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America IVF and ICSI Pipettes Sales by Country (2021–2032)
3.4.3 North America IVF and ICSI Pipettes Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe IVF and ICSI Pipettes Market Facts & Figures by Country
3.5.1 Europe IVF and ICSI Pipettes Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe IVF and ICSI Pipettes Sales by Country (2021–2032)
3.5.3 Europe IVF and ICSI Pipettes Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific IVF and ICSI Pipettes Market Facts & Figures by Region
3.6.1 Asia Pacific IVF and ICSI Pipettes Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific IVF and ICSI Pipettes Sales by Region (2021–2032)
3.6.3 Asia Pacific IVF and ICSI Pipettes Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America IVF and ICSI Pipettes Market Facts & Figures by Country
3.7.1 Latin America IVF and ICSI Pipettes Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America IVF and ICSI Pipettes Sales by Country (2021–2032)
3.7.3 Latin America IVF and ICSI Pipettes Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa IVF and ICSI Pipettes Market Facts & Figures by Country
3.8.1 Middle East and Africa IVF and ICSI Pipettes Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa IVF and ICSI Pipettes Sales by Country (2021–2032)
3.8.3 Middle East and Africa IVF and ICSI Pipettes Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global IVF and ICSI Pipettes Sales by Type (2021–2032)
4.1.1 Global IVF and ICSI Pipettes Sales by Type (2021–2026)
4.1.2 Global IVF and ICSI Pipettes Sales by Type (2027–2032)
4.1.3 Global IVF and ICSI Pipettes Sales Market Share by Type (2021–2032)
4.2 Global IVF and ICSI Pipettes Revenue by Type (2021–2032)
4.2.1 Global IVF and ICSI Pipettes Revenue by Type (2021–2026)
4.2.2 Global IVF and ICSI Pipettes Revenue by Type (2027–2032)
4.2.3 Global IVF and ICSI Pipettes Revenue Market Share by Type (2021–2032)
4.3 Global IVF and ICSI Pipettes Price by Type (2021–2032)
5 Segment by Application
5.1 Global IVF and ICSI Pipettes Sales by Application (2021–2032)
5.1.1 Global IVF and ICSI Pipettes Sales by Application (2021–2026)
5.1.2 Global IVF and ICSI Pipettes Sales by Application (2027–2032)
5.1.3 Global IVF and ICSI Pipettes Sales Market Share by Application (2021–2032)
5.2 Global IVF and ICSI Pipettes Revenue by Application (2021–2032)
5.2.1 Global IVF and ICSI Pipettes Revenue by Application (2021–2026)
5.2.2 Global IVF and ICSI Pipettes Revenue by Application (2027–2032)
5.2.3 Global IVF and ICSI Pipettes Revenue Market Share by Application (2021–2032)
5.3 Global IVF and ICSI Pipettes Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Cook Medical
6.1.1 Cook Medical Company Information
6.1.2 Cook Medical Description and Business Overview
6.1.3 Cook Medical IVF and ICSI Pipettes Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Cook Medical IVF and ICSI Pipettes Product Portfolio
6.1.5 Cook Medical Recent Developments/Updates
6.2 CooperSurgical
6.2.1 CooperSurgical Company Information
6.2.2 CooperSurgical Description and Business Overview
6.2.3 CooperSurgical IVF and ICSI Pipettes Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 CooperSurgical IVF and ICSI Pipettes Product Portfolio
6.2.5 CooperSurgical Recent Developments/Updates
6.3 Sunlight Medical
6.3.1 Sunlight Medical Company Information
6.3.2 Sunlight Medical Description and Business Overview
6.3.3 Sunlight Medical IVF and ICSI Pipettes Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Sunlight Medical IVF and ICSI Pipettes Product Portfolio
6.3.5 Sunlight Medical Recent Developments/Updates
6.4 Vitrolife
6.4.1 Vitrolife Company Information
6.4.2 Vitrolife Description and Business Overview
6.4.3 Vitrolife IVF and ICSI Pipettes Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Vitrolife IVF and ICSI Pipettes Product Portfolio
6.4.5 Vitrolife Recent Developments/Updates
6.5 Kitazato
6.5.1 Kitazato Company Information
6.5.2 Kitazato Description and Business Overview
6.5.3 Kitazato IVF and ICSI Pipettes Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Kitazato IVF and ICSI Pipettes Product Portfolio
6.5.5 Kitazato Recent Developments/Updates
6.6 Synga
6.6.1 Synga Company Information
6.6.2 Synga Description and Business Overview
6.6.3 Synga IVF and ICSI Pipettes Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Synga IVF and ICSI Pipettes Product Portfolio
6.6.5 Synga Recent Developments/Updates
6.7 Microtech
6.7.1 Microtech Company Information
6.7.2 Microtech Description and Business Overview
6.7.3 Microtech IVF and ICSI Pipettes Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Microtech IVF and ICSI Pipettes Product Portfolio
6.7.5 Microtech Recent Developments/Updates
6.8 Hamilton Thorne
6.8.1 Hamilton Thorne Company Information
6.8.2 Hamilton Thorne Description and Business Overview
6.8.3 Hamilton Thorne IVF and ICSI Pipettes Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Hamilton Thorne IVF and ICSI Pipettes Product Portfolio
6.8.5 Hamilton Thorne Recent Developments/Updates
6.9 ASTEC Pipette
6.9.1 ASTEC Pipette Company Information
6.9.2 ASTEC Pipette Description and Business Overview
6.9.3 ASTEC Pipette IVF and ICSI Pipettes Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 ASTEC Pipette IVF and ICSI Pipettes Product Portfolio
6.9.5 ASTEC Pipette Recent Developments/Updates
6.10 Cryo Bio System
6.10.1 Cryo Bio System Company Information
6.10.2 Cryo Bio System Description and Business Overview
6.10.3 Cryo Bio System IVF and ICSI Pipettes Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Cryo Bio System IVF and ICSI Pipettes Product Portfolio
6.10.5 Cryo Bio System Recent Developments/Updates
6.11 WEIGAO
6.11.1 WEIGAO Company Information
6.11.2 WEIGAO Description and Business Overview
6.11.3 WEIGAO IVF and ICSI Pipettes Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 WEIGAO IVF and ICSI Pipettes Product Portfolio
6.11.5 WEIGAO Recent Developments/Updates
6.12 Lingen Precision Medical
6.12.1 Lingen Precision Medical Company Information
6.12.2 Lingen Precision Medical Description and Business Overview
6.12.3 Lingen Precision Medical IVF and ICSI Pipettes Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Lingen Precision Medical IVF and ICSI Pipettes Product Portfolio
6.12.5 Lingen Precision Medical Recent Developments/Updates
6.13 FUJIFILM Irvine Scientific
6.13.1 FUJIFILM Irvine Scientific Company Information
6.13.2 FUJIFILM Irvine Scientific Description and Business Overview
6.13.3 FUJIFILM Irvine Scientific IVF and ICSI Pipettes Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 FUJIFILM Irvine Scientific IVF and ICSI Pipettes Product Portfolio
6.13.5 FUJIFILM Irvine Scientific Recent Developments/Updates
6.14 Diagens Biotechnology
6.14.1 Diagens Biotechnology Company Information
6.14.2 Diagens Biotechnology Description and Business Overview
6.14.3 Diagens Biotechnology IVF and ICSI Pipettes Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Diagens Biotechnology IVF and ICSI Pipettes Product Portfolio
6.14.5 Diagens Biotechnology Recent Developments/Updates
6.15 Optimas
6.15.1 Optimas Company Information
6.15.2 Optimas Description and Business Overview
6.15.3 Optimas IVF and ICSI Pipettes Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Optimas IVF and ICSI Pipettes Product Portfolio
6.15.5 Optimas Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 IVF and ICSI Pipettes Industry Chain Analysis
7.2 IVF and ICSI Pipettes Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 IVF and ICSI Pipettes Production Mode & Process Analysis
7.4 IVF and ICSI Pipettes Sales and Marketing
7.4.1 IVF and ICSI Pipettes Sales Channels
7.4.2 IVF and ICSI Pipettes Distributors
7.5 IVF and ICSI Pipettes Customer Analysis
8 IVF and ICSI Pipettes Market Dynamics
8.1 IVF and ICSI Pipettes Industry Trends
8.2 IVF and ICSI Pipettes Market Drivers
8.3 IVF and ICSI Pipettes Market Challenges
8.4 IVF and ICSI Pipettes Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global IVF and ICSI Pipettes Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global IVF and ICSI Pipettes Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global IVF and ICSI Pipettes Market Competitive Situation by Manufacturers in 2025
 Table 4. Global IVF and ICSI Pipettes Sales (Units) of Key Manufacturers (2021–2026)
 Table 5. Global IVF and ICSI Pipettes Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global IVF and ICSI Pipettes Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global IVF and ICSI Pipettes Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market IVF and ICSI Pipettes Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of IVF and ICSI Pipettes, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of IVF and ICSI Pipettes, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of IVF and ICSI Pipettes, Product Types and Applications
 Table 12. Global Key Manufacturers of IVF and ICSI Pipettes, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global IVF and ICSI Pipettes Companies by Tier (Tier 1, Tier 2, Tier 3), based on IVF and ICSI Pipettes Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global IVF and ICSI Pipettes Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global IVF and ICSI Pipettes Sales by Region (Units), 2021–2026
 Table 18. Global IVF and ICSI Pipettes Sales Market Share by Region (2021–2026)
 Table 19. Global IVF and ICSI Pipettes Sales by Region (Units), 2027–2032
 Table 20. Global IVF and ICSI Pipettes Sales Market Share by Region (2027–2032)
 Table 21. Global IVF and ICSI Pipettes Revenue by Region (US$ Million), 2021–2026
 Table 22. Global IVF and ICSI Pipettes Revenue Market Share by Region (2021–2026)
 Table 23. Global IVF and ICSI Pipettes Revenue by Region (US$ Million), 2027–2032
 Table 24. Global IVF and ICSI Pipettes Revenue Market Share by Region (2027–2032)
 Table 25. North America IVF and ICSI Pipettes Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America IVF and ICSI Pipettes Sales by Country (Units), 2021–2026
 Table 27. North America IVF and ICSI Pipettes Sales by Country (Units), 2027–2032
 Table 28. North America IVF and ICSI Pipettes Revenue by Country (US$ Million), 2021–2026
 Table 29. North America IVF and ICSI Pipettes Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe IVF and ICSI Pipettes Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe IVF and ICSI Pipettes Sales by Country (Units), 2021–2026
 Table 32. Europe IVF and ICSI Pipettes Sales by Country (Units), 2027–2032
 Table 33. Europe IVF and ICSI Pipettes Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe IVF and ICSI Pipettes Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific IVF and ICSI Pipettes Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific IVF and ICSI Pipettes Sales by Region (Units), 2021–2026
 Table 37. Asia Pacific IVF and ICSI Pipettes Sales by Region (Units), 2027–2032
 Table 38. Asia Pacific IVF and ICSI Pipettes Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific IVF and ICSI Pipettes Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America IVF and ICSI Pipettes Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America IVF and ICSI Pipettes Sales by Country (Units), 2021–2026
 Table 42. Latin America IVF and ICSI Pipettes Sales by Country (Units), 2027–2032
 Table 43. Latin America IVF and ICSI Pipettes Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America IVF and ICSI Pipettes Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa IVF and ICSI Pipettes Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa IVF and ICSI Pipettes Sales by Country (Units), 2021–2026
 Table 47. Middle East and Africa IVF and ICSI Pipettes Sales by Country (Units), 2027–2032
 Table 48. Middle East and Africa IVF and ICSI Pipettes Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa IVF and ICSI Pipettes Revenue by Country (US$ Million), 2027–2032
 Table 50. Global IVF and ICSI Pipettes Sales (Units) by Type (2021–2026)
 Table 51. Global IVF and ICSI Pipettes Sales (Units) by Type (2027–2032)
 Table 52. Global IVF and ICSI Pipettes Sales Market Share by Type (2021–2026)
 Table 53. Global IVF and ICSI Pipettes Sales Market Share by Type (2027–2032)
 Table 54. Global IVF and ICSI Pipettes Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global IVF and ICSI Pipettes Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global IVF and ICSI Pipettes Revenue Market Share by Type (2021–2026)
 Table 57. Global IVF and ICSI Pipettes Revenue Market Share by Type (2027–2032)
 Table 58. Global IVF and ICSI Pipettes Price (US$/Unit) by Type (2021–2026)
 Table 59. Global IVF and ICSI Pipettes Price (US$/Unit) by Type (2027–2032)
 Table 60. Global IVF and ICSI Pipettes Sales (Units) by Application (2021–2026)
 Table 61. Global IVF and ICSI Pipettes Sales (Units) by Application (2027–2032)
 Table 62. Global IVF and ICSI Pipettes Sales Market Share by Application (2021–2026)
 Table 63. Global IVF and ICSI Pipettes Sales Market Share by Application (2027–2032)
 Table 64. Global IVF and ICSI Pipettes Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global IVF and ICSI Pipettes Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global IVF and ICSI Pipettes Revenue Market Share by Application (2021–2026)
 Table 67. Global IVF and ICSI Pipettes Revenue Market Share by Application (2027–2032)
 Table 68. Global IVF and ICSI Pipettes Price (US$/Unit) by Application (2021–2026)
 Table 69. Global IVF and ICSI Pipettes Price (US$/Unit) by Application (2027–2032)
 Table 70. Cook Medical Company Information
 Table 71. Cook Medical Description and Business Overview
 Table 72. Cook Medical IVF and ICSI Pipettes Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Cook Medical IVF and ICSI Pipettes Product
 Table 74. Cook Medical Recent Developments/Updates
 Table 75. CooperSurgical Company Information
 Table 76. CooperSurgical Description and Business Overview
 Table 77. CooperSurgical IVF and ICSI Pipettes Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. CooperSurgical IVF and ICSI Pipettes Product
 Table 79. CooperSurgical Recent Developments/Updates
 Table 80. Sunlight Medical Company Information
 Table 81. Sunlight Medical Description and Business Overview
 Table 82. Sunlight Medical IVF and ICSI Pipettes Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Sunlight Medical IVF and ICSI Pipettes Product
 Table 84. Sunlight Medical Recent Developments/Updates
 Table 85. Vitrolife Company Information
 Table 86. Vitrolife Description and Business Overview
 Table 87. Vitrolife IVF and ICSI Pipettes Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Vitrolife IVF and ICSI Pipettes Product
 Table 89. Vitrolife Recent Developments/Updates
 Table 90. Kitazato Company Information
 Table 91. Kitazato Description and Business Overview
 Table 92. Kitazato IVF and ICSI Pipettes Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Kitazato IVF and ICSI Pipettes Product
 Table 94. Kitazato Recent Developments/Updates
 Table 95. Synga Company Information
 Table 96. Synga Description and Business Overview
 Table 97. Synga IVF and ICSI Pipettes Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Synga IVF and ICSI Pipettes Product
 Table 99. Synga Recent Developments/Updates
 Table 100. Microtech Company Information
 Table 101. Microtech Description and Business Overview
 Table 102. Microtech IVF and ICSI Pipettes Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Microtech IVF and ICSI Pipettes Product
 Table 104. Microtech Recent Developments/Updates
 Table 105. Hamilton Thorne Company Information
 Table 106. Hamilton Thorne Description and Business Overview
 Table 107. Hamilton Thorne IVF and ICSI Pipettes Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Hamilton Thorne IVF and ICSI Pipettes Product
 Table 109. Hamilton Thorne Recent Developments/Updates
 Table 110. ASTEC Pipette Company Information
 Table 111. ASTEC Pipette Description and Business Overview
 Table 112. ASTEC Pipette IVF and ICSI Pipettes Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. ASTEC Pipette IVF and ICSI Pipettes Product
 Table 114. ASTEC Pipette Recent Developments/Updates
 Table 115. Cryo Bio System Company Information
 Table 116. Cryo Bio System Description and Business Overview
 Table 117. Cryo Bio System IVF and ICSI Pipettes Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Cryo Bio System IVF and ICSI Pipettes Product
 Table 119. Cryo Bio System Recent Developments/Updates
 Table 120. WEIGAO Company Information
 Table 121. WEIGAO Description and Business Overview
 Table 122. WEIGAO IVF and ICSI Pipettes Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. WEIGAO IVF and ICSI Pipettes Product
 Table 124. WEIGAO Recent Developments/Updates
 Table 125. Lingen Precision Medical Company Information
 Table 126. Lingen Precision Medical Description and Business Overview
 Table 127. Lingen Precision Medical IVF and ICSI Pipettes Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 128. Lingen Precision Medical IVF and ICSI Pipettes Product
 Table 129. Lingen Precision Medical Recent Developments/Updates
 Table 130. FUJIFILM Irvine Scientific Company Information
 Table 131. FUJIFILM Irvine Scientific Description and Business Overview
 Table 132. FUJIFILM Irvine Scientific IVF and ICSI Pipettes Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 133. FUJIFILM Irvine Scientific IVF and ICSI Pipettes Product
 Table 134. FUJIFILM Irvine Scientific Recent Developments/Updates
 Table 135. Diagens Biotechnology Company Information
 Table 136. Diagens Biotechnology Description and Business Overview
 Table 137. Diagens Biotechnology IVF and ICSI Pipettes Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 138. Diagens Biotechnology IVF and ICSI Pipettes Product
 Table 139. Diagens Biotechnology Recent Developments/Updates
 Table 140. Optimas Company Information
 Table 141. Optimas Description and Business Overview
 Table 142. Optimas IVF and ICSI Pipettes Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 143. Optimas IVF and ICSI Pipettes Product
 Table 144. Optimas Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. IVF and ICSI Pipettes Distributors List
 Table 148. IVF and ICSI Pipettes Customers List
 Table 149. IVF and ICSI Pipettes Market Trends
 Table 150. IVF and ICSI Pipettes Market Drivers
 Table 151. IVF and ICSI Pipettes Market Challenges
 Table 152. IVF and ICSI Pipettes Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of IVF and ICSI Pipettes
 Figure 2. Global IVF and ICSI Pipettes Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global IVF and ICSI Pipettes Market Share by Type: 2025 & 2032
 Figure 4. Sharp Pipettes Product Picture
 Figure 5. Blunt Pipettes Product Picture
 Figure 6. Global IVF and ICSI Pipettes Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global IVF and ICSI Pipettes Market Share by Application: 2025 & 2032
 Figure 8. Fertility Clinics
 Figure 9. Hospitals
 Figure 10. Research Institutes
 Figure 11. Global IVF and ICSI Pipettes Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global IVF and ICSI Pipettes Market Size (US$ Million), 2021–2032
 Figure 13. Global IVF and ICSI Pipettes Sales (Units), 2021–2032
 Figure 14. Global IVF and ICSI Pipettes Average Price (US$/Unit), 2021–2032
 Figure 15. IVF and ICSI Pipettes Report Years Considered
 Figure 16. IVF and ICSI Pipettes Sales Share by Manufacturers in 2025
 Figure 17. Global IVF and ICSI Pipettes Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global IVF and ICSI Pipettes Players: Market Share by Revenue in IVF and ICSI Pipettes in 2025
 Figure 19. IVF and ICSI Pipettes Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global IVF and ICSI Pipettes Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America IVF and ICSI Pipettes Sales Market Share by Country (2021–2032)
 Figure 22. North America IVF and ICSI Pipettes Revenue Market Share by Country (2021–2032)
 Figure 23. United States IVF and ICSI Pipettes Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada IVF and ICSI Pipettes Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe IVF and ICSI Pipettes Sales Market Share by Country (2021–2032)
 Figure 26. Europe IVF and ICSI Pipettes Revenue Market Share by Country (2021–2032)
 Figure 27. Germany IVF and ICSI Pipettes Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France IVF and ICSI Pipettes Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. IVF and ICSI Pipettes Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy IVF and ICSI Pipettes Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia IVF and ICSI Pipettes Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific IVF and ICSI Pipettes Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific IVF and ICSI Pipettes Revenue Market Share by Region (2021–2032)
 Figure 34. China IVF and ICSI Pipettes Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan IVF and ICSI Pipettes Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea IVF and ICSI Pipettes Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India IVF and ICSI Pipettes Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia IVF and ICSI Pipettes Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. China Taiwan IVF and ICSI Pipettes Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Southeast Asia IVF and ICSI Pipettes Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Latin America IVF and ICSI Pipettes Sales Market Share by Country (2021–2032)
 Figure 42. Latin America IVF and ICSI Pipettes Revenue Market Share by Country (2021–2032)
 Figure 43. Mexico IVF and ICSI Pipettes Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Brazil IVF and ICSI Pipettes Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Argentina IVF and ICSI Pipettes Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Colombia IVF and ICSI Pipettes Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Middle East and Africa IVF and ICSI Pipettes Sales Market Share by Country (2021–2032)
 Figure 48. Middle East and Africa IVF and ICSI Pipettes Revenue Market Share by Country (2021–2032)
 Figure 49. Turkey IVF and ICSI Pipettes Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Saudi Arabia IVF and ICSI Pipettes Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. UAE IVF and ICSI Pipettes Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Global Sales Market Share of IVF and ICSI Pipettes by Type (2021–2032)
 Figure 53. Global Revenue Market Share of IVF and ICSI Pipettes by Type (2021–2032)
 Figure 54. Global IVF and ICSI Pipettes Price (US$/Unit) by Type (2021–2032)
 Figure 55. Global Sales Market Share of IVF and ICSI Pipettes by Application (2021–2032)
 Figure 56. Global Revenue Market Share of IVF and ICSI Pipettes by Application (2021–2032)
 Figure 57. Global IVF and ICSI Pipettes Price (US$/Unit) by Application (2021–2032)
 Figure 58. IVF and ICSI Pipettes Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network